Back

Results - Announcements

Sales rise 10.86% to Rs 502.45 crore

Caplin Point Laboratories consolidated net profit rises 17.25% in the March 2025 quarter

15-May-2025, 03:43
Net profit of Caplin Point Laboratories rose 17.25% to Rs 142.57 crore in the quarter ended March 2025 as against Rs 121.59 crore during the previous quarter ended March 2024. Sales rose 10.86% to Rs 502.45 crore in the quarter ended March 2025 as against Rs 453.22 crore during the previous quarter ended March 2024.

For the full year,net profit rose 17.33% to Rs 536.31 crore in the year ended March 2025 as against Rs 457.09 crore during the previous year ended March 2024. Sales rose 14.37% to Rs 1937.47 crore in the year ended March 2025 as against Rs 1694.10 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	502.45	453.22	11	1937.47	1694.10	14
OPM %	33.45	32.04	-	33.39	32.55	-
PBDT	193.71	162.43	19	742.74	617.87	20
PBT	176.67	146.03	21	676.78	564.43	20
NP	142.57	121.59	17	536.31	457.09	17